loading
Precedente Chiudi:
$245.47
Aprire:
$249.03
Volume 24 ore:
6,071
Relative Volume:
0.02
Capitalizzazione di mercato:
$5.71B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-9.4204
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
+4.15%
1M Prestazione:
+9.33%
6M Prestazione:
-26.94%
1 anno Prestazione:
-15.63%
Intervallo 1D:
Value
$249.03
$259.29
Intervallo di 1 settimana:
Value
$237.63
$259.29
Portata 52W:
Value
$211.43
$387.99

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name
Nome
Bio Rad Laboratories Inc
Name
Telefono
(510) 724-7000
Name
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Name
Dipendente
7,700
Name
Cinguettio
@BioRadLifeSci
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
BIO's Discussions on Twitter

Confronta BIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
BIO
Bio Rad Laboratories Inc
257.67 6.73B 2.58B -778.69M 223.75M -27.33
Medical Devices icon
ABT
Abbott Laboratories
124.41 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
107.24 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
399.50 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.79 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.98 45.06B 5.54B 4.18B 623.10M 7.00

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-01 Aggiornamento Citigroup Neutral → Buy
2024-08-28 Iniziato Wells Fargo Equal Weight
2024-06-03 Ripresa Jefferies Hold
2024-04-03 Downgrade Citigroup Buy → Neutral
2023-12-07 Iniziato UBS Buy
2023-06-16 Iniziato Wells Fargo Overweight
2022-12-07 Iniziato RBC Capital Mkts Outperform
2022-08-25 Iniziato Credit Suisse Outperform
2022-01-28 Reiterato Citigroup Buy
2020-01-08 Iniziato Wells Fargo Overweight
2020-01-07 Iniziato Citigroup Buy
2018-10-17 Iniziato Goldman Buy
2018-09-20 Iniziato Morgan Stanley Equal-Weight
2018-02-16 Downgrade CL King Buy → Neutral
2017-07-13 Iniziato Wells Fargo Outperform
2017-06-28 Aggiornamento Deutsche Bank Hold → Buy
2017-01-18 Iniziato Deutsche Bank Hold
2016-10-13 Iniziato CL King Buy
2015-05-06 Reiterato Jefferies Buy
2009-12-18 Iniziato Maxim Group Buy
2009-11-06 Iniziato Jefferies & Co Buy
2009-07-17 Iniziato Soleil Buy
2007-09-26 Iniziato Banc of America Sec Buy
2007-02-23 Downgrade Robert W. Baird Outperform → Neutral
Mostra tutto

Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie

pulisher
08:23 AM

Unexpected Trends Reshaping the Chromatography Resin Market - openPR.com

08:23 AM
pulisher
08:13 AM

How the Polymerase Chain Reaction Market Will Evolve by 2032 - openPR.com

08:13 AM
pulisher
08:08 AM

Bio Rad Laboratories Inc. Stock Analysis and ForecastFast-track wealth growth - Autocar Professional

08:08 AM
pulisher
07:03 AM

Is Bio Rad Laboratories Inc. a good long term investmentMarket-leading profit generation - jammulinksnews.com

07:03 AM
pulisher
06:04 AM

Hydroxyapatite Market Size, Share 2025 Analysis of Rising - openPR.com

06:04 AM
pulisher
04:06 AM

Protein Chip Market Generated Opportunities, Future Scope - openPR.com

04:06 AM
pulisher
Jul 22, 2025

Single-cell Omics Market Analysis, Insights and Forecast from - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

HbA1c Testing Market Expansion Driven by Diabetes Prevalence - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Medical Biosensors Market is projected to grow to around USD - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Flow Cytometry in Oncology and Immunology Market Top Companies - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Bio Rad Laboratories Inc. stockHigh-octane investment gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

Viral Vector Purification Market Top Companies StudyAgilent - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Cancer Biomarkers Market is expected to reach USD 32.5 billion - openPR.com

Jul 21, 2025
pulisher
Jul 18, 2025

How high can Bio Rad Laboratories Inc. stock price go in 2025Stable Stocks With High Yield - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

Future Industry Growth Of Real-Time Polymerase Chain Reaction - openPR.com

Jul 18, 2025
pulisher
Jul 17, 2025

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025 - BioSpace

Jul 17, 2025
pulisher
Jul 17, 2025

Biochip Market Global Outlook Report 2025, with Focus on Microarrays and Lab-on-a-Chip - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 17, 2025

Unexpected Trends Reshaping the Cancer Biomarkers Market - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

Laboratory Mixer Market Gains Momentum with Automation - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

Trending Report on Liquid-Based Diagnostics Market 2025-2032 - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

Bioinformatics Market Exclusive Report with Detailed Study - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

Enzyme Linked Immunosorbent Assay Market Set to Expand Through - openPR.com

Jul 17, 2025
pulisher
Jul 16, 2025

Global Liquid Biopsy Market Size Worth USD 25.24 Billion By 2032 | - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

Single Cell Omics Market Size, Share, Industry Growth Report - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific - Yahoo Finance

Jul 16, 2025
pulisher
Jul 14, 2025

Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms - Yahoo Finance

Jul 14, 2025
pulisher
Jul 09, 2025

Protein Chip Market Booming as High-Throughput Proteomics - openPR.com

Jul 09, 2025
pulisher
Jul 08, 2025

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout - drugdiscoverynews.com

Jul 08, 2025
pulisher
Jul 08, 2025

Bio-Rad expands Droplet Digital PCR offering through strategic acquisition and platform rollout - SelectScience

Jul 08, 2025
pulisher
Jul 08, 2025

Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Shareholders Might Be Looking For Exit - 富途牛牛

Jul 08, 2025
pulisher
Jul 07, 2025

Bio-Rad's Digital PCR Play: A Strategic Move to Dominate Genomics and Diagnostics - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Bio-Rad expands digital PCR portfolio with four new platforms By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Bio-Rad Labs announces launch of four new Droplet Digital PCR platforms - BioSpectrum India

Jul 07, 2025
pulisher
Jul 07, 2025

Bio-Rad expands digital PCR portfolio with four new platforms - Investing.com

Jul 07, 2025
pulisher
Jul 02, 2025

Single-cell Omics Market Projected To Witness Massive Growth, - openPR.com

Jul 02, 2025
pulisher
Jul 01, 2025

Trend Tracker for (BIO.B) - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jul 01, 2025

RBC Raises Price Target on Bio-Rad Laboratories to $387 From $381, Keeps Outperform Rating - MarketScreener

Jul 01, 2025
pulisher
Jun 30, 2025

Bio-Rad Completes Acquisition of Stilla Technologies - TipRanks

Jun 30, 2025

Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$285.53
price down icon 0.06%
medical_devices STE
$224.49
price up icon 0.28%
medical_devices PHG
$25.59
price up icon 2.20%
$85.96
price up icon 0.99%
$77.17
price up icon 0.88%
medical_devices EW
$76.98
price up icon 0.88%
Capitalizzazione:     |  Volume (24 ore):